Brainstorm Cell Therapeutics Inc. (NASDAQ:BCLI) shares fell to a low of $3.76 before closing at $3.76. Intraday shares traded counted 0.61 million, which was -2.2%
Brainstorm Cell Therapeutics Inc. (NASDAQ:BCLI) Relative Strength Index (RSI) is 64.20, with weekly volatility at 8.95% and ATR at 0.22. The BCLI stock’s 52-week price
Discover high-quality information at your convenience with ‘State Reviewer.’ Our news portal offers valuable insights for free, available in accessible locations such as metro stations, busy intersections, cafes, and business centers. Wherever your day takes you, ‘State Reviewer’ ensures you’re never out of touch with the latest news and updates.
All rights reserved © 2024, Powered by Smart TechOne